LIFE SCIENCES IN PARIS REGION PARIS AREA : FIRST EUROPEAN REGION IN - - PowerPoint PPT Presentation

▶

Mar 11, 2023 223 likes •424 views

LIFE SCIENCES IN PARIS REGION PARIS AREA : FIRST EUROPEAN REGION IN THE FIELD OF LIFE SCIENCE AND HEALTH % of GDP allocated to R&D 3.1% Total private R&D investment Bn 11.3 Total public R&D investment Bn

SLIDE 1

LIFE SCIENCES IN PARIS REGION

SLIDE 2

PARIS AREA : FIRST EUROPEAN REGION IN THE FIELD OF LIFE SCIENCE AND HEALTH  1st for pharmaceuticals  2nd in medtech  3rd in biotechnology  1st in public sector research  Europe’s largest hospital network (the AP-HP, Paris Public Hospitals Group)

▪ % of GDP allocated to R&D 3.1% ▪ Total private R&D investment Bn€ 11.3 ▪ Total public R&D investment Bn€ 6.1 ▪ Economic growth 0.3% ▪ Life sciences companies 1,000+ (2014) ▪ Number of employees 36,600 (2011) ▪ Students with tertiary education 635,353 ▪ Number of researchers 91,000 (2012) of which 11,900 in life sciences ▪ Number of scientific publications 23,813

SLIDE 3

MEDICEN PARIS REGION

CONNECTING THE STAKEHOLDERS

Paris Region Assets

▪ 45% of the Academic Research in Life sciences, chemistry, and ICT in France ▪ Europe’s largest hospital network

Medicen Paris Region Assets:

▪ One of Europe’s biggest life sciences’

clusters ▪ A unique forum connecting ALL of the stakeholders that INNOVATE in Health:

300+ Members
27 Large companies
200+ innovative SMEs
272 Funded projects / 1,1 billions €

investment ▪ Unique Collaboration in Connected Health

Academics

Large companies

SMEs Physicians

SLIDE 4

Academics Large companies

Territorial collectivities

SLIDE 5

SMES: NEARLY 200 INNOVATIVE ACTORS

SLIDE 6

MEDICEN PARIS REGION ACTIONS

NETWORKING & EVENTS FOSTER R&D COLLABORATIVE PROJECTS ACCELERATE ECONOMIC DEVELOPMENT OF SMEs ATTRACTIVENESS AND INTERNATIONAL DELEGATIONS

SLIDE 7

MEDICEN PARIS REGION

5 KEY AREAS ACROSS PERSONALIZED MEDICINE

Biomarkers Companion diagnostics Reagents Laboratory equipment Prevention, screening, diagnostic, monitoring and therapeutic care of pathologies Imaging (bio)markers In vivo guidance Therapeutic targeting Gene therapies Cell therapies Tissue engineering Innovative treatments Molecular technologies

SLIDE 8

OPPORTUNITIES IN PARIS REGION BIOCLUSTER

WHAT CAN MEDICEN DO FOR YOU ?

Network and connections

Identify/get you in touch with the right Industry/academia partners
Help you to get in touch with other bioclusters & ecosystems

Projects expertise

R&D Collaborative projects: engineering and access to public finance
Advice you on appropriate call submission

Strategic orientations (2016-2018) :

Make things changing in the field of : Transplantation, diabete, immuno-onco, parkinson , psychiatric diseases (raising collaborative projects)

SLIDE 9

KEY FIGURES

49 products on the market 13 services 16 process 28 prototypes

Out of 54 achieved projects

1,1 billion € of

investment

479 million €

Of public aides

272

projets accredited and financed

24

PME helped in fund-raising

300+ members

Including 27 large groups

SLIDE 10

EUROPEAN INTERCLUSTERING NETWORK

One Nucleus CBN /UKTI / Catapults Asebio Biocat Cluster Oslo Medtech / Cancer Cluster BioM Berlin Partner FlandersBio BioWin Lifetech Brussells Medicon Valley Innovation Quarter Health Holland OOSTNV Health Valley

Medicen member of the clusters’ associations CEBR & EDCA Associate partner of EIT HEALTH

Swiss Business Hub Innovaud Biopole Medtech cluster Invest in Scotland Regmed center Enterprise Ireland Invest in Skane Medeon Uppsala Bio… HealthTech Cluster Medical Valley

HISTORIC PARTNERS NEW PARTNERS OTHER CONTACTS

SLIDE 11

THANK YOU FOR YOUR ATTENTION!

www.medicen.org

fontaine@medicen.org

SLIDE 12

LIFE SCIENCES IN THE PARIS REGION

SLIDE 13

SLIDE 14

SLIDE 15

PARIS REGION

EXCELLENCE IN BIOTECHNOLOGIES

Incubateur Boucicaut

SLIDE 16

PARIS REGION: BIOTECH EXCELLENCE HIGHLIGHTS

Genopôle Evry

(Gene Therapies, cellular Therapies, Nursery, R&D Platforms)

Cancer Campus

Villejuif Biopark

(Cancer Research, Clinical trials, Translationnal medecine, Nursery)

Biocitech

(Nursery,R&D platforms)

Paris Saclay Campus

(CEA Neurospin, R&D platforms Universities, Nursery)

SLIDE 17

PARIS REGION: BIOTECH EXCELLENCE HIGHLIGHTS (2)

Paris

AP-HP Hospital

ICM

(Brain & Spine Institute)

(Neuroscience, Clinical trials, Translationnal medecine, Nursery)

Institut de la Vision

(Eye Pathology, Clinical trials, Translationnal medecine, Nursery)

Institut Curie

( PACRI network, Cancer Research, Clinical trials, Translationnal medecine)

Pasteur Institute

(Immunology, Infectiology)

HepatInnov

(Paul Brousse Hospital, Hepatology & Translationnal Medecine)

Boucicaut e-Health Nursery

(e-Health technologies start-up)

SLIDE 18

CLINICAL VALIDATION OPPORTUNITIES IN PARIS REGION BIOCLUSTER

AP-HP : THE LARGEST HOSPITAL NETWORK IN EUROPE (37 HOSPITALS)

Necker

Histologie-Embryologie-Cytogénétique Hématologie Biochimie générale et métabolique Génétique des déficits Immunitaires héréditaires

Cochin

Tumorothèque : dermatologie, gynécologie, urologie Parasitologie-Mycologie Biochimie metabolique Auto-immunité, vaccinologie et cancérologie NGS - Ion Proton et Ion PGM, LifeTechnologies

HEGP

Microbiologie, virologie, résistance antibiotique Anapathologie oncologie

Tenon

Marqueurs cardiaques/insuline Génomique des tumeurs

Robert Debré

Microbiologie phylogénétique E.Coli

Trousseau

Biologie pédiatrique, urgences Virologie et virologie persistante Génomique de s tumeurs Diagnostic moléculaire des hémopathies myéloïdes

Saint Antoine

Morphologie anathomo-cytologie Diagnostic moléculaire des hémopathies myéloïdes

Lariboisière

Bactériologie infectiologie

Saint Louis

Greffe et transplantation

➢ 1350 biologists (AP-HP)